USNA's Brent Neidig Sells Shares as Institutional Investors Adjust Positions
Brent Neidig sold 1,602 shares of USNA on June 12, 2026, for $32,280.
Key Points
- Brent Neidig, Chief Commercial Officer of USNA, sold 1,602 shares worth $32,280 on June 12, 2026.
- Shares of USNA traded at $19.41 with institutional investors like BlackRock making significant adjustments to their holdings.
- Analyst firm D.A. Davidson has maintained a 'hold' rating on USNA, with recent price targets ranging from $36 to $62.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Brent Neidig, the Chief Commercial Officer of USNA, sold 1,602 shares of the company on June 12, 2026. The transaction was valued at $32,280, with an average selling price of $20.15 per share. This sale was not part of a pre-planned trading program.
Insider Buying and Selling at USANA Health Sciences, Inc.
Brent Neidig has been active in selling USNA shares, having sold 909 shares on June 15, 2026, at an average price of $20.01. Other insiders have also sold shares recently, including Paul Jones, the Chief People Officer, who sold 5,561 shares on June 8, 2026, at $18.50 per share.
Other Institutional Activity in USNA
Institutional investors have been adjusting their stakes in USNA. BlackRock, Inc. increased its holdings by 78,415 shares, bringing its total to 1,190,416 shares worth about $20.8 million. Pzena Investment Management LLC reduced its position by 25,496 shares, ending with 1,108,933 shares valued at approximately $19.4 million. Renaissance Technologies LLC also reduced its stake by 129,693 shares, holding 1,017,630 shares valued at $17.8 million. Meanwhile, Nantahala Capital Management, LLC significantly increased its holdings by 225,000 shares, resulting in a total of 810,074 shares worth about $14.2 million.
USANA Health Sciences, Inc. Stock Up 38.2%
Shares of USNA are trading at approximately $19.41. The stock has experienced various institutional movements, reflecting differing investment strategies among major shareholders.
Analysts Set New Price Targets
D.A. Davidson has maintained a 'hold' rating on USNA, with recent price targets ranging from $36 to $62. The firm's most recent target, set on February 27, 2025, is $36.
Bottom Line
Brent Neidig's recent sale of USNA shares comes amid notable institutional changes in the company's ownership. While insiders and large funds adjust their positions, analysts like D.A. Davidson continue to hold a steady outlook on the stock. Investors watch these moves closely, though it's important to remember that such filings are reported after the fact and may not reflect the current state of holdings.
Get USANA Health Sciences, Inc. alerts
New 13F filings, insider trades, and analyst moves on $USNA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.